The 20th Bio€quity Europe : Hot Topics, Hot Spots
Biotech is entering a golden age. The world is seeing a flood of new therapies that have long been the promise of this industry.
Gene Therapies. Stem Cell Treatments. Antisense. siRNA. CAR T.
Is Europe playing its part?
Are they holding their own in inventing the next-generation of therapies and technologies?
And is Europe creating hot beds of innovation to lead the way forward?
For 20 years, Bio€quity Europe has been holding up a mirror to reflect Europe’s progress in the biotech revolution.
Today, even more exciting science and technologies are on the horizon. But the momentum is global. Europe must keep pace to attract the best talent and investment, create jobs and improve public health.
In 2019, Bio€quity Europe gathers European “Hot Topics” companies and their investors to measure their progress and debate the path forward.
For 20 years, Bio€quity Europe has showcased more than 800 leading European companies to thousands of investment and pharma business development professionals. Delegates from 24 nations attended Bio€quity Europe last year in Ghent.